The Christie NHS Foundation

Manchester M20 4GJ

1 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, FGFR2 Gene Fusion/Rearrangement, Mantle Cell Lymphoma, Metastatic Breast Cancer, Myelodysplastic Syndrome, Non-Small Cell Lung Cancer, Other Solid Tumors, Adult

Studies at this site

• A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement — Recruiting now
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer — Completed
• Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies — Completed